Baumann P, Nyman J, Hoyer M et al (2009) Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27:3290–3296. https://doi.org/10.1200/JCO.2008.21.5681

Article  PubMed  Google Scholar 

Brandner ED, Chetty IJ, Giaddui TG, Xiao Y, Huq MS (2017) Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: a review from NRG oncology. Med Phys 44:2595–2612. https://doi.org/10.1002/mp.12227

Article  PubMed  Google Scholar 

Ehrbar S, Johl A, Tartas A et al (2017) ITV, mid-ventilation, gating or couch tracking - a comparison of respiratory motion-management techniques based on 4D dose calculations. Radiother Oncol 124:80–88. https://doi.org/10.1016/j.radonc.2017.05.016

Article  PubMed  Google Scholar 

Giraud P, Houle A (2013) Respiratory gating for radiotherapy: main technical aspects and clinical benefits. ISRN Pulmonology 2013:519602. https://doi.org/10.1155/2013/519602

Article  Google Scholar 

Hanley J, Debois MM, Mah D et al (1999) Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys 45:603–611. https://doi.org/10.1016/s0360-3016(99)00154-6

CAS  Article  PubMed  Google Scholar 

Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K (2007) Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 110:148–155. https://doi.org/10.1002/cncr.22763

Article  PubMed  Google Scholar 

Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC (2013) Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143:e278S-e313S. https://doi.org/10.1378/chest.12-2359

CAS  Article  PubMed  Google Scholar 

Kim J, Wu Q, Zhao B, Wen N, Ajlouni M, Movsas B, Chetty IJ (2016) To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer. Radiat Oncol 11:125. https://doi.org/10.1186/s13014-016-0699-2

CAS  Article  PubMed  PubMed Central  Google Scholar 

Koto M, Takai Y, Ogawa Y et al (2007) A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 85:429–434. https://doi.org/10.1016/j.radonc.2007.10.017

Article  PubMed  Google Scholar 

Lee P, Loo BW Jr, Biswas T et al (2021) Local control after stereotactic body radiation therapy for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 110:160–171. https://doi.org/10.1016/j.ijrobp.2019.03.045

Article  PubMed  Google Scholar 

Matsuo Y, Shibuya K, Nakamura M et al (2012) Dose–volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 83:e545-549. https://doi.org/10.1016/j.ijrobp.2012.01.018

Article  PubMed  Google Scholar 

Molitoris JK, Diwanji T, Snider JW 3rd et al (2018) Advances in the use of motion management and image guidance in radiation therapy treatment for lung cancer. J Thorac Dis 10:S2437–S2450. https://doi.org/10.21037/jtd.2018.01.155

Article  PubMed  PubMed Central  Google Scholar 

Murray P, Franks K, Hanna GG (2017) A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer. Br J Radiol 90:20160732. https://doi.org/10.1259/bjr.20160732

Article  PubMed  PubMed Central  Google Scholar 

Nagata Y, Takayama K, Matsuo Y et al (2005) Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63:1427–1431. https://doi.org/10.1016/j.ijrobp.2005.05.034

Article  PubMed  Google Scholar 

Nissen HD, Appelt AL (2013) Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients. Radiother Oncol 106:28–32. https://doi.org/10.1016/j.radonc.2012.10.016

Article  PubMed  Google Scholar 

Oechsner M, Dusberg M, Borm KJ, Combs SE, Wilkens JJ, Duma MN (2019) Deep inspiration breath-hold for left-sided breast irradiation: analysis of dose-mass histograms and the impact of lung expansion. Radiat Oncol 14:109. https://doi.org/10.1186/s13014-019-1293-1

Article  PubMed  PubMed Central  Google Scholar 

Onishi H, Shirato H, Nagata Y et al (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2:S94-100. https://doi.org/10.1097/JTO.0b013e318074de34

Article  PubMed  Google Scholar 

Palma DA, Olson R, Harrow S et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393:2051–2058. https://doi.org/10.1016/s0140-6736(18)32487-5

Article  PubMed  Google Scholar 

Park K, Vansteenkiste J, Lee KH et al (2020) Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. Ann Oncol 31:191–201. https://doi.org/10.1016/j.annonc.2019.10.026

CAS  Article  PubMed  Google Scholar 

Prunaretty J, Boisselier P, Ailleres N et al (2019) Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison. Rep Pract Oncol Radiother 24:97–104. https://doi.org/10.1016/j.rpor.2018.11.003

Article  PubMed  Google Scholar 

Remouchamps VM, Vicini FA, Sharpe MB, Kestin LL, Martinez AA, Wong JW (2003) Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 55:392–406. https://doi.org/10.1016/s0360-3016(02)04143-3

Article  PubMed  Google Scholar 

Sawant A, Keall P, Pauly KB et al (2014) Investigating the feasibility of rapid MRI for image-guided motion management in lung cancer radiotherapy. Biomed Res Int 2014:485067. https://doi.org/10.1155/2014/485067

Article  PubMed  PubMed Central  Google Scholar 

Shibamoto Y, Hashizume C, Baba F et al (2015) Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results. J Thorac Oncol 10:960–964. https://doi.org/10.1097/jto.0000000000000525

CAS  Article  PubMed  Google Scholar 

Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A (2018) Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol 45:210–219. https://doi.org/10.1053/j.seminoncol.2018.06.002

Article  PubMed  Google Scholar 

Shirato H, Onimaru R, Ishikawa M et al (2012) Real-time 4-D radiotherapy for lung cancer. Cancer Sci 103:1–6. https://doi.org/10.1111/j.1349-7006.2011.02114.x

CAS  Article  PubMed  Google Scholar 

Shultz DB, Filippi AR, Thariat J, Mornex F, Loo BW Jr, Ricardi U (2014) Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer. J Thorac Oncol 9:1426–1433. https://doi.org/10.1097/jto.0000000000000317

Article  PubMed  Google Scholar 

Temming S, Kocher M, Stoelben E et al (2018) Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer. Strahlenther Onkol 194:91–97. https://doi.org/10.1007/s00066-017-1194-x

Article  PubMed  Google Scholar 

Timmerman RD, Paulus R, Pass HI et al (2018) Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG oncology RTOG 0618 trial. JAMA Oncol 4:1263–1266. https://doi.org/10.1001/jamaoncol.2018.1251

Article  PubMed  PubMed Central  Google Scholar 

Videtic GM, Paulus R, Singh AK et al (2019) Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. Int J Radiat Oncol Biol Phys 103:1077–1084. https://doi.org/10.1016/j.ijrobp.2018.11.051

Article  PubMed  Google Scholar 

Wojcieszynski AP, Hill PM, Rosenberg SA et al (2017) Dosimetric comparison of real-time MRI-guided tri-cobalt-60 versus linear accelerator-based stereotactic body radiation therapy lung cancer plans. Technol Cancer Res Treat 16:366–372. https://doi.org/10.1177/1533034617691407

CAS  Article  PubMed  PubMed Central  Google Scholar 

Yamada Y, Yamada M, Chubachi S et al (2020) Comparison of inspiratory and expiratory lung and lobe volumes among supine, standing, and sitting positions using conventional and upright CT. Sci Rep 10:16203. https://doi.org/10.1038/s41598-020-73240-8

CAS  Article  PubMed  PubMed Central  Google Scholar 

Zhao J, Yorke ED, Li L et al (2016) Simple factors associated with radiation-induced lung toxicity after stereotactic body radiation therapy of the thorax: a pooled analysis of 88 studies. Int J Radiat Oncol Biol Phys 95:1357–1366. https://doi.org/10.1016/j.ijrobp.2016.03.024

Article  PubMed  PubMed Central  Google Scholar